Addyi was the first drug approved to treat FSIAD. Addyi is designed for premenopausal people, and is available as a pill. A person takes this drug daily before bed, even if they do not intend to ...

Recursion Pharmaceuticals is a pioneer in AI-powered drug discovery but faces challenges in monetizing its innovations and aligning management's vision with sustainable revenue paths. The company ...

This may look like: forgetting to take your pill within the same three-hour window each day incorrectly applying a new skin patch inserting a new vaginal ring a day later than expected missing ...

The overall stock market decline likely weighed on Recursion's shares. CNBC host Jim Cramer's recent hesitation about the biotech stock could also be causing angst for investors. Part of the ...

In Benue State, he noted that operatives intercepted a vehicle at Ugbema Junction, Katsina-Ala, on Wednesday, March 5, recovering 50,000 pills of tramadol and Exol-5 from two suspects, Nwaeze ...

Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to Recursion Pharmaceuticals (NASDAQ: RXRX). The company has emerged as a ...

Hims Hard Mints are a discreet alternative to erectile dysfunction pills. They’re created by a process called compounding. Compounded medications are customized or altered to meet a specific ...

Machine-learning techniques keep improving efficiency in one industry after another. One corner of the economy where investors expect another big leap forward is the world of drug development.